Shopping Cart 0
Cart Subtotal
USD 0

Global Herceptin Biosimilar Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 4880

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 7320

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 9760

Details

Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein.

Scope of the Report:

The worldwide market for Herceptin Biosimilar is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2024, from xx million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Herceptin Biosimilar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Amgen

AryoGen Biopharma

Biocon

Celltrion

Gedeon Richter

Genor Biopharma

Mabion

Mylan

Roche

The Instituto Vital Brazil

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Breast Cancer

Colorectal Cancer

Leukemia

Lymphoma

Other

Market Segment by Applications, can be divided into

Hospital & Clinics

Oncology Centers

Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Herceptin Biosimilar product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Herceptin Biosimilar, with price, sales, revenue and global market share of Herceptin Biosimilar in 2017 and 2018.

Chapter 3, the Herceptin Biosimilar competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Herceptin Biosimilar breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Herceptin Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Herceptin Biosimilar sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Herceptin Biosimilar Introduction

1.2 Market Analysis by Type

1.2.1 Breast Cancer

1.2.2 Colorectal Cancer

1.2.3 Leukemia

1.2.4 Lymphoma

1.2.5 Other

1.3 Market Analysis by Applications

1.3.1 Hospital & Clinics

1.3.2 Oncology Centers

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Business Overview

2.1.2 Herceptin Biosimilar Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 AryoGen Biopharma

2.2.1 Business Overview

2.2.2 Herceptin Biosimilar Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Biocon

2.3.1 Business Overview

2.3.2 Herceptin Biosimilar Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biocon Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Celltrion

2.4.1 Business Overview

2.4.2 Herceptin Biosimilar Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Celltrion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Gedeon Richter

2.5.1 Business Overview

2.5.2 Herceptin Biosimilar Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Gedeon Richter Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Genor Biopharma

2.6.1 Business Overview

2.6.2 Herceptin Biosimilar Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Genor Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Mabion

2.7.1 Business Overview

2.7.2 Herceptin Biosimilar Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Mabion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Mylan

2.8.1 Business Overview

2.8.2 Herceptin Biosimilar Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Mylan Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Roche

2.9.1 Business Overview

2.9.2 Herceptin Biosimilar Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Roche Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 The Instituto Vital Brazil

2.10.1 Business Overview

2.10.2 Herceptin Biosimilar Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Herceptin Biosimilar Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Herceptin Biosimilar Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Herceptin Biosimilar Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Herceptin Biosimilar Manufacturer Market Share in 2018

3.3.2 Top 6 Herceptin Biosimilar Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Herceptin Biosimilar Market Analysis by Regions

4.1 Global Herceptin Biosimilar Sales, Revenue and Market Share by Regions

4.1.1 Global Herceptin Biosimilar Sales and Market Share by Regions (2014-2019)

4.1.2 Global Herceptin Biosimilar Revenue and Market Share by Regions (2014-2019)

4.2 North America Herceptin Biosimilar Sales and Growth Rate (2014-2019)

4.3 Europe Herceptin Biosimilar Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Herceptin Biosimilar Sales and Growth Rate (2014-2019)

4.5 South America Herceptin Biosimilar Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)

5 North America Herceptin Biosimilar by Country

5.1 North America Herceptin Biosimilar Sales, Revenue and Market Share by Country

5.1.1 North America Herceptin Biosimilar Sales and Market Share by Country (2014-2019)

5.1.2 North America Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)

5.2 United States Herceptin Biosimilar Sales and Growth Rate (2014-2019)

5.3 Canada Herceptin Biosimilar Sales and Growth Rate (2014-2019)

5.4 Mexico Herceptin Biosimilar Sales and Growth Rate (2014-2019)

6 Europe Herceptin Biosimilar by Country

6.1 Europe Herceptin Biosimilar Sales, Revenue and Market Share by Country

6.1.1 Europe Herceptin Biosimilar Sales and Market Share by Country (2014-2019)

6.1.2 Europe Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)

6.2 Germany Herceptin Biosimilar Sales and Growth Rate (2014-2019)

6.3 UK Herceptin Biosimilar Sales and Growth Rate (2014-2019)

6.4 France Herceptin Biosimilar Sales and Growth Rate (2014-2019)

6.5 Russia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

6.6 Italy Herceptin Biosimilar Sales and Growth Rate (2014-2019)

7 Asia-Pacific Herceptin Biosimilar by Country

7.1 Asia-Pacific Herceptin Biosimilar Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Herceptin Biosimilar Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)

7.2 China Herceptin Biosimilar Sales and Growth Rate (2014-2019)

7.3 Japan Herceptin Biosimilar Sales and Growth Rate (2014-2019)

7.4 Korea Herceptin Biosimilar Sales and Growth Rate (2014-2019)

7.5 India Herceptin Biosimilar Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

8 South America Herceptin Biosimilar by Country

8.1 South America Herceptin Biosimilar Sales, Revenue and Market Share by Country

8.1.1 South America Herceptin Biosimilar Sales and Market Share by Country (2014-2019)

8.1.2 South America Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)

8.2 Brazil Herceptin Biosimilar Sales and Growth Rate (2014-2019)

8.3 Argentina Herceptin Biosimilar Sales and Growth Rate (2014-2019)

8.4 Colombia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

9 Middle East and Africa Herceptin Biosimilar by Countries

9.1 Middle East and Africa Herceptin Biosimilar Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Herceptin Biosimilar Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

9.3 Turkey Herceptin Biosimilar Sales and Growth Rate (2014-2019)

9.4 Egypt Herceptin Biosimilar Sales and Growth Rate (2014-2019)

9.5 Nigeria Herceptin Biosimilar Sales and Growth Rate (2014-2019)

9.6 South Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)

10 Global Herceptin Biosimilar Market Segment by Type

10.1 Global Herceptin Biosimilar Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Herceptin Biosimilar Sales and Market Share by Type (2014-2019)

10.1.2 Global Herceptin Biosimilar Revenue and Market Share by Type (2014-2019)

10.2 Breast Cancer Sales Growth and Price

10.2.1 Global Breast Cancer Sales Growth (2014-2019)

10.2.2 Global Breast Cancer Price (2014-2019)

10.3 Colorectal Cancer Sales Growth and Price

10.3.1 Global Colorectal Cancer Sales Growth (2014-2019)

10.3.2 Global Colorectal Cancer Price (2014-2019)

10.4 Leukemia Sales Growth and Price

10.4.1 Global Leukemia Sales Growth (2014-2019)

10.4.2 Global Leukemia Price (2014-2019)

10.5 Lymphoma Sales Growth and Price

10.5.1 Global Lymphoma Sales Growth (2014-2019)

10.5.2 Global Lymphoma Price (2014-2019)

10.6 Other Sales Growth and Price

10.6.1 Global Other Sales Growth (2014-2019)

10.6.2 Global Other Price (2014-2019)

11 Global Herceptin Biosimilar Market Segment by Application

11.1 Global Herceptin Biosimilar Sales Market Share by Application (2014-2019)

11.2 Hospital & Clinics Sales Growth (2014-2019)

11.3 Oncology Centers Sales Growth (2014-2019)

11.4 Other Sales Growth (2014-2019)

12 Herceptin Biosimilar Market Forecast (2019-2024)

12.1 Global Herceptin Biosimilar Sales, Revenue and Growth Rate (2019-2024)

12.2 Herceptin Biosimilar Market Forecast by Regions (2019-2024)

12.2.1 North America Herceptin Biosimilar Market Forecast (2019-2024)

12.2.2 Europe Herceptin Biosimilar Market Forecast (2019-2024)

12.2.3 Asia-Pacific Herceptin Biosimilar Market Forecast (2019-2024)

12.2.4 South America Herceptin Biosimilar Market Forecast (2019-2024)

12.2.5 Middle East and Africa Herceptin Biosimilar Market Forecast (2019-2024)

12.3 Herceptin Biosimilar Market Forecast by Type (2019-2024)

12.3.1 Global Herceptin Biosimilar Sales Forecast by Type (2019-2024)

12.3.2 Global Herceptin Biosimilar Market Share Forecast by Type (2019-2024)

12.4 Herceptin Biosimilar Market Forecast by Application (2019-2024)

12.4.1 Global Herceptin Biosimilar Sales Forecast by Application (2019-2024)

12.4.2 Global Herceptin Biosimilar Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Herceptin Biosimilar Picture

Table Product Specifications of Herceptin Biosimilar

Figure Global Sales Market Share of Herceptin Biosimilar by Types in 2018

Table Herceptin Biosimilar Types for Major Manufacturers

Figure Breast Cancer Picture

Figure Colorectal Cancer Picture

Figure Leukemia Picture

Figure Lymphoma Picture

Figure Other Picture

Figure Herceptin Biosimilar Sales Market Share by Applications in 2018

Figure Hospital & Clinics Picture

Figure Oncology Centers Picture

Figure Other Picture

Figure United States Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Canada Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Germany Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure France Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure UK Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Russia Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Italy Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure China Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Japan Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Korea Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure India Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Herceptin Biosimilar Type and Applications

Table Amgen Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table AryoGen Biopharma Basic Information, Manufacturing Base and Competitors

Table AryoGen Biopharma Herceptin Biosimilar Type and Applications

Table AryoGen Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Biocon Basic Information, Manufacturing Base and Competitors

Table Biocon Herceptin Biosimilar Type and Applications

Table Biocon Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Celltrion Basic Information, Manufacturing Base and Competitors

Table Celltrion Herceptin Biosimilar Type and Applications

Table Celltrion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Gedeon Richter Basic Information, Manufacturing Base and Competitors

Table Gedeon Richter Herceptin Biosimilar Type and Applications

Table Gedeon Richter Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Genor Biopharma Basic Information, Manufacturing Base and Competitors

Table Genor Biopharma Herceptin Biosimilar Type and Applications

Table Genor Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Mabion Basic Information, Manufacturing Base and Competitors

Table Mabion Herceptin Biosimilar Type and Applications

Table Mabion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Herceptin Biosimilar Type and Applications

Table Mylan Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Herceptin Biosimilar Type and Applications

Table Roche Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table The Instituto Vital Brazil Basic Information, Manufacturing Base and Competitors

Table The Instituto Vital Brazil Herceptin Biosimilar Type and Applications

Table The Instituto Vital Brazil Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global Herceptin Biosimilar Sales by Manufacturer (2017-2018)

Figure Global Herceptin Biosimilar Sales Market Share by Manufacturer in 2017

Figure Global Herceptin Biosimilar Sales Market Share by Manufacturer in 2018

Table Global Herceptin Biosimilar Revenue by Manufacturer (2017-2018)

Figure Global Herceptin Biosimilar Revenue Market Share by Manufacturer in 2017

Figure Global Herceptin Biosimilar Revenue Market Share by Manufacturer in 2018

Figure Top 3 Herceptin Biosimilar Manufacturer (Revenue) Market Share in 2018

Figure Top 6 Herceptin Biosimilar Manufacturer (Revenue) Market Share in 2018

Figure Global Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Global Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table Global Herceptin Biosimilar Sales by Regions (2014-2019)

Table Global Herceptin Biosimilar Sales Market Share by Regions (2014-2019)

Table Global Herceptin Biosimilar Revenue by Regions (2014-2019)

Figure Global Herceptin Biosimilar Revenue Market Share by Regions (2014-2019)

Figure Global Herceptin Biosimilar Revenue Market Share by Regions in 2018

Figure North America Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Europe Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure South America Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure North America Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table North America Herceptin Biosimilar Sales by Countries (2014-2019)

Table North America Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Figure North America Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Figure North America Herceptin Biosimilar Sales Market Share by Countries in 2018

Table North America Herceptin Biosimilar Revenue by Countries (2014-2019)

Table North America Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure North America Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure North America Herceptin Biosimilar Revenue Market Share by Countries in 2018

Figure United States Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Canada Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Mexico Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Europe Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table Europe Herceptin Biosimilar Sales by Countries (2014-2019)

Table Europe Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Table Europe Herceptin Biosimilar Revenue by Countries (2014-2019)

Figure Europe Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure Europe Herceptin Biosimilar Revenue Market Share by Countries in 2018

Figure Germany Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure UK Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure France Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Russia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Italy Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Herceptin Biosimilar Sales by Countries (2014-2019)

Table Asia-Pacific Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific Herceptin Biosimilar Sales Market Share by Countries 2018

Table Asia-Pacific Herceptin Biosimilar Revenue by Countries (2014-2019)

Figure Asia-Pacific Herceptin Biosimilar Revenue Market Share by Countries 2018

Figure China Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Japan Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Korea Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure India Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Southeast Asia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure South America Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table South America Herceptin Biosimilar Sales by Countries (2014-2019)

Table South America Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Figure South America Herceptin Biosimilar Sales Market Share by Countries in 2018

Table South America Herceptin Biosimilar Revenue by Countries (2014-2019)

Table South America Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure South America Herceptin Biosimilar Revenue Market Share by Countries in 2018

Figure Brazil Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Argentina Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Colombia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Herceptin Biosimilar Sales by Countries (2014-2019)

Table Middle East and Africa Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa Herceptin Biosimilar Sales Market Share by Countries in 2018

Table Middle East and Africa Herceptin Biosimilar Revenue by Countries (2014-2019)

Table Middle East and Africa Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Herceptin Biosimilar Revenue Market Share by Countries in 2018

Figure Saudi Arabia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure UAE Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Egypt Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Nigeria Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure South Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Table Global Herceptin Biosimilar Sales by Type (2014-2019)

Table Global Herceptin Biosimilar Sales Share by Type (2014-2019)

Table Global Herceptin Biosimilar Revenue by Type (2014-2019)

Table Global Herceptin Biosimilar Revenue Share by Type (2014-2019)

Figure Global Breast Cancer Sales Growth (2014-2019)

Figure Global Breast Cancer Price (2014-2019)

Figure Global Colorectal Cancer Sales Growth (2014-2019)

Figure Global Colorectal Cancer Price (2014-2019)

Figure Global Leukemia Sales Growth (2014-2019)

Figure Global Leukemia Price (2014-2019)

Figure Global Lymphoma Sales Growth (2014-2019)

Figure Global Lymphoma Price (2014-2019)

Figure Global Other Sales Growth (2014-2019)

Figure Global Other Price (2014-2019)

Table Global Herceptin Biosimilar Sales by Application (2014-2019)

Table Global Herceptin Biosimilar Sales Share by Application (2014-2019)

Figure Global Oncology Centers Sales Growth (2014-2019)

Figure Global Other Sales Growth (2014-2019)

Figure Global Herceptin Biosimilar Sales, Revenue and Growth Rate (2019-2024)

Table Global Herceptin Biosimilar Sales Forecast by Regions (2019-2024)

Table Global Herceptin Biosimilar Market Share Forecast by Regions (2019-2024)

Figure North America Sales Herceptin Biosimilar Market Forecast (2019-2024)

Figure Europe Sales Herceptin Biosimilar Market Forecast (2019-2024)

Figure Asia-Pacific Sales Herceptin Biosimilar Market Forecast (2019-2024)

Figure South America Sales Herceptin Biosimilar Market Forecast (2019-2024)

Figure Middle East and Africa Sales Herceptin Biosimilar Market Forecast (2019-2024)

Table Global Herceptin Biosimilar Sales Forecast by Type (2019-2024)

Table Global Herceptin Biosimilar Market Share Forecast by Type (2019-2024)

Table Global Herceptin Biosimilar Sales Forecast by Application (2019-2024)

Table Global Herceptin Biosimilar Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Amgen

AryoGen Biopharma

Biocon

Celltrion

Gedeon Richter

Genor Biopharma

Mabion

Mylan

Roche

The Instituto Vital Brazil

Company Profile

Company Profile Title

Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein.

Scope of the Report:

The worldwide market for Herceptin Biosimilar is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2024, from xx million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Herceptin Biosimilar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Amgen

AryoGen Biopharma

Biocon

Celltrion

Gedeon Richter

Genor Biopharma

Mabion

Mylan

Roche

The Instituto Vital Brazil

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Breast Cancer

Colorectal Cancer

Leukemia

Lymphoma

Other

Market Segment by Applications, can be divided into

Hospital & Clinics

Oncology Centers

Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Herceptin Biosimilar product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Herceptin Biosimilar, with price, sales, revenue and global market share of Herceptin Biosimilar in 2017 and 2018.

Chapter 3, the Herceptin Biosimilar competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Herceptin Biosimilar breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Herceptin Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Herceptin Biosimilar sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Herceptin Biosimilar Introduction

1.2 Market Analysis by Type

1.2.1 Breast Cancer

1.2.2 Colorectal Cancer

1.2.3 Leukemia

1.2.4 Lymphoma

1.2.5 Other

1.3 Market Analysis by Applications

1.3.1 Hospital & Clinics

1.3.2 Oncology Centers

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Business Overview

2.1.2 Herceptin Biosimilar Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 AryoGen Biopharma

2.2.1 Business Overview

2.2.2 Herceptin Biosimilar Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Biocon

2.3.1 Business Overview

2.3.2 Herceptin Biosimilar Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biocon Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Celltrion

2.4.1 Business Overview

2.4.2 Herceptin Biosimilar Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Celltrion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Gedeon Richter

2.5.1 Business Overview

2.5.2 Herceptin Biosimilar Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Gedeon Richter Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Genor Biopharma

2.6.1 Business Overview

2.6.2 Herceptin Biosimilar Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Genor Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Mabion

2.7.1 Business Overview

2.7.2 Herceptin Biosimilar Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Mabion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Mylan

2.8.1 Business Overview

2.8.2 Herceptin Biosimilar Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Mylan Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Roche

2.9.1 Business Overview

2.9.2 Herceptin Biosimilar Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Roche Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 The Instituto Vital Brazil

2.10.1 Business Overview

2.10.2 Herceptin Biosimilar Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Herceptin Biosimilar Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Herceptin Biosimilar Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Herceptin Biosimilar Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Herceptin Biosimilar Manufacturer Market Share in 2018

3.3.2 Top 6 Herceptin Biosimilar Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Herceptin Biosimilar Market Analysis by Regions

4.1 Global Herceptin Biosimilar Sales, Revenue and Market Share by Regions

4.1.1 Global Herceptin Biosimilar Sales and Market Share by Regions (2014-2019)

4.1.2 Global Herceptin Biosimilar Revenue and Market Share by Regions (2014-2019)

4.2 North America Herceptin Biosimilar Sales and Growth Rate (2014-2019)

4.3 Europe Herceptin Biosimilar Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Herceptin Biosimilar Sales and Growth Rate (2014-2019)

4.5 South America Herceptin Biosimilar Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)

5 North America Herceptin Biosimilar by Country

5.1 North America Herceptin Biosimilar Sales, Revenue and Market Share by Country

5.1.1 North America Herceptin Biosimilar Sales and Market Share by Country (2014-2019)

5.1.2 North America Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)

5.2 United States Herceptin Biosimilar Sales and Growth Rate (2014-2019)

5.3 Canada Herceptin Biosimilar Sales and Growth Rate (2014-2019)

5.4 Mexico Herceptin Biosimilar Sales and Growth Rate (2014-2019)

6 Europe Herceptin Biosimilar by Country

6.1 Europe Herceptin Biosimilar Sales, Revenue and Market Share by Country

6.1.1 Europe Herceptin Biosimilar Sales and Market Share by Country (2014-2019)

6.1.2 Europe Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)

6.2 Germany Herceptin Biosimilar Sales and Growth Rate (2014-2019)

6.3 UK Herceptin Biosimilar Sales and Growth Rate (2014-2019)

6.4 France Herceptin Biosimilar Sales and Growth Rate (2014-2019)

6.5 Russia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

6.6 Italy Herceptin Biosimilar Sales and Growth Rate (2014-2019)

7 Asia-Pacific Herceptin Biosimilar by Country

7.1 Asia-Pacific Herceptin Biosimilar Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Herceptin Biosimilar Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)

7.2 China Herceptin Biosimilar Sales and Growth Rate (2014-2019)

7.3 Japan Herceptin Biosimilar Sales and Growth Rate (2014-2019)

7.4 Korea Herceptin Biosimilar Sales and Growth Rate (2014-2019)

7.5 India Herceptin Biosimilar Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

8 South America Herceptin Biosimilar by Country

8.1 South America Herceptin Biosimilar Sales, Revenue and Market Share by Country

8.1.1 South America Herceptin Biosimilar Sales and Market Share by Country (2014-2019)

8.1.2 South America Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)

8.2 Brazil Herceptin Biosimilar Sales and Growth Rate (2014-2019)

8.3 Argentina Herceptin Biosimilar Sales and Growth Rate (2014-2019)

8.4 Colombia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

9 Middle East and Africa Herceptin Biosimilar by Countries

9.1 Middle East and Africa Herceptin Biosimilar Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Herceptin Biosimilar Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

9.3 Turkey Herceptin Biosimilar Sales and Growth Rate (2014-2019)

9.4 Egypt Herceptin Biosimilar Sales and Growth Rate (2014-2019)

9.5 Nigeria Herceptin Biosimilar Sales and Growth Rate (2014-2019)

9.6 South Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)

10 Global Herceptin Biosimilar Market Segment by Type

10.1 Global Herceptin Biosimilar Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Herceptin Biosimilar Sales and Market Share by Type (2014-2019)

10.1.2 Global Herceptin Biosimilar Revenue and Market Share by Type (2014-2019)

10.2 Breast Cancer Sales Growth and Price

10.2.1 Global Breast Cancer Sales Growth (2014-2019)

10.2.2 Global Breast Cancer Price (2014-2019)

10.3 Colorectal Cancer Sales Growth and Price

10.3.1 Global Colorectal Cancer Sales Growth (2014-2019)

10.3.2 Global Colorectal Cancer Price (2014-2019)

10.4 Leukemia Sales Growth and Price

10.4.1 Global Leukemia Sales Growth (2014-2019)

10.4.2 Global Leukemia Price (2014-2019)

10.5 Lymphoma Sales Growth and Price

10.5.1 Global Lymphoma Sales Growth (2014-2019)

10.5.2 Global Lymphoma Price (2014-2019)

10.6 Other Sales Growth and Price

10.6.1 Global Other Sales Growth (2014-2019)

10.6.2 Global Other Price (2014-2019)

11 Global Herceptin Biosimilar Market Segment by Application

11.1 Global Herceptin Biosimilar Sales Market Share by Application (2014-2019)

11.2 Hospital & Clinics Sales Growth (2014-2019)

11.3 Oncology Centers Sales Growth (2014-2019)

11.4 Other Sales Growth (2014-2019)

12 Herceptin Biosimilar Market Forecast (2019-2024)

12.1 Global Herceptin Biosimilar Sales, Revenue and Growth Rate (2019-2024)

12.2 Herceptin Biosimilar Market Forecast by Regions (2019-2024)

12.2.1 North America Herceptin Biosimilar Market Forecast (2019-2024)

12.2.2 Europe Herceptin Biosimilar Market Forecast (2019-2024)

12.2.3 Asia-Pacific Herceptin Biosimilar Market Forecast (2019-2024)

12.2.4 South America Herceptin Biosimilar Market Forecast (2019-2024)

12.2.5 Middle East and Africa Herceptin Biosimilar Market Forecast (2019-2024)

12.3 Herceptin Biosimilar Market Forecast by Type (2019-2024)

12.3.1 Global Herceptin Biosimilar Sales Forecast by Type (2019-2024)

12.3.2 Global Herceptin Biosimilar Market Share Forecast by Type (2019-2024)

12.4 Herceptin Biosimilar Market Forecast by Application (2019-2024)

12.4.1 Global Herceptin Biosimilar Sales Forecast by Application (2019-2024)

12.4.2 Global Herceptin Biosimilar Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Herceptin Biosimilar Picture

Table Product Specifications of Herceptin Biosimilar

Figure Global Sales Market Share of Herceptin Biosimilar by Types in 2018

Table Herceptin Biosimilar Types for Major Manufacturers

Figure Breast Cancer Picture

Figure Colorectal Cancer Picture

Figure Leukemia Picture

Figure Lymphoma Picture

Figure Other Picture

Figure Herceptin Biosimilar Sales Market Share by Applications in 2018

Figure Hospital & Clinics Picture

Figure Oncology Centers Picture

Figure Other Picture

Figure United States Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Canada Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Germany Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure France Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure UK Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Russia Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Italy Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure China Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Japan Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Korea Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure India Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Herceptin Biosimilar Type and Applications

Table Amgen Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table AryoGen Biopharma Basic Information, Manufacturing Base and Competitors

Table AryoGen Biopharma Herceptin Biosimilar Type and Applications

Table AryoGen Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Biocon Basic Information, Manufacturing Base and Competitors

Table Biocon Herceptin Biosimilar Type and Applications

Table Biocon Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Celltrion Basic Information, Manufacturing Base and Competitors

Table Celltrion Herceptin Biosimilar Type and Applications

Table Celltrion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Gedeon Richter Basic Information, Manufacturing Base and Competitors

Table Gedeon Richter Herceptin Biosimilar Type and Applications

Table Gedeon Richter Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Genor Biopharma Basic Information, Manufacturing Base and Competitors

Table Genor Biopharma Herceptin Biosimilar Type and Applications

Table Genor Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Mabion Basic Information, Manufacturing Base and Competitors

Table Mabion Herceptin Biosimilar Type and Applications

Table Mabion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Herceptin Biosimilar Type and Applications

Table Mylan Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Herceptin Biosimilar Type and Applications

Table Roche Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table The Instituto Vital Brazil Basic Information, Manufacturing Base and Competitors

Table The Instituto Vital Brazil Herceptin Biosimilar Type and Applications

Table The Instituto Vital Brazil Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global Herceptin Biosimilar Sales by Manufacturer (2017-2018)

Figure Global Herceptin Biosimilar Sales Market Share by Manufacturer in 2017

Figure Global Herceptin Biosimilar Sales Market Share by Manufacturer in 2018

Table Global Herceptin Biosimilar Revenue by Manufacturer (2017-2018)

Figure Global Herceptin Biosimilar Revenue Market Share by Manufacturer in 2017

Figure Global Herceptin Biosimilar Revenue Market Share by Manufacturer in 2018

Figure Top 3 Herceptin Biosimilar Manufacturer (Revenue) Market Share in 2018

Figure Top 6 Herceptin Biosimilar Manufacturer (Revenue) Market Share in 2018

Figure Global Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Global Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table Global Herceptin Biosimilar Sales by Regions (2014-2019)

Table Global Herceptin Biosimilar Sales Market Share by Regions (2014-2019)

Table Global Herceptin Biosimilar Revenue by Regions (2014-2019)

Figure Global Herceptin Biosimilar Revenue Market Share by Regions (2014-2019)

Figure Global Herceptin Biosimilar Revenue Market Share by Regions in 2018

Figure North America Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Europe Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure South America Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure North America Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table North America Herceptin Biosimilar Sales by Countries (2014-2019)

Table North America Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Figure North America Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Figure North America Herceptin Biosimilar Sales Market Share by Countries in 2018

Table North America Herceptin Biosimilar Revenue by Countries (2014-2019)

Table North America Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure North America Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure North America Herceptin Biosimilar Revenue Market Share by Countries in 2018

Figure United States Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Canada Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Mexico Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Europe Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table Europe Herceptin Biosimilar Sales by Countries (2014-2019)

Table Europe Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Table Europe Herceptin Biosimilar Revenue by Countries (2014-2019)

Figure Europe Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure Europe Herceptin Biosimilar Revenue Market Share by Countries in 2018

Figure Germany Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure UK Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure France Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Russia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Italy Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Herceptin Biosimilar Sales by Countries (2014-2019)

Table Asia-Pacific Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific Herceptin Biosimilar Sales Market Share by Countries 2018

Table Asia-Pacific Herceptin Biosimilar Revenue by Countries (2014-2019)

Figure Asia-Pacific Herceptin Biosimilar Revenue Market Share by Countries 2018

Figure China Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Japan Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Korea Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure India Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Southeast Asia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure South America Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table South America Herceptin Biosimilar Sales by Countries (2014-2019)

Table South America Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Figure South America Herceptin Biosimilar Sales Market Share by Countries in 2018

Table South America Herceptin Biosimilar Revenue by Countries (2014-2019)

Table South America Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure South America Herceptin Biosimilar Revenue Market Share by Countries in 2018

Figure Brazil Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Argentina Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Colombia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Herceptin Biosimilar Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Herceptin Biosimilar Sales by Countries (2014-2019)

Table Middle East and Africa Herceptin Biosimilar Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa Herceptin Biosimilar Sales Market Share by Countries in 2018

Table Middle East and Africa Herceptin Biosimilar Revenue by Countries (2014-2019)

Table Middle East and Africa Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Herceptin Biosimilar Revenue Market Share by Countries in 2018

Figure Saudi Arabia Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure UAE Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Egypt Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure Nigeria Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Figure South Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)

Table Global Herceptin Biosimilar Sales by Type (2014-2019)

Table Global Herceptin Biosimilar Sales Share by Type (2014-2019)

Table Global Herceptin Biosimilar Revenue by Type (2014-2019)

Table Global Herceptin Biosimilar Revenue Share by Type (2014-2019)

Figure Global Breast Cancer Sales Growth (2014-2019)

Figure Global Breast Cancer Price (2014-2019)

Figure Global Colorectal Cancer Sales Growth (2014-2019)

Figure Global Colorectal Cancer Price (2014-2019)

Figure Global Leukemia Sales Growth (2014-2019)

Figure Global Leukemia Price (2014-2019)

Figure Global Lymphoma Sales Growth (2014-2019)

Figure Global Lymphoma Price (2014-2019)

Figure Global Other Sales Growth (2014-2019)

Figure Global Other Price (2014-2019)

Table Global Herceptin Biosimilar Sales by Application (2014-2019)

Table Global Herceptin Biosimilar Sales Share by Application (2014-2019)

Figure Global Oncology Centers Sales Growth (2014-2019)

Figure Global Other Sales Growth (2014-2019)

Figure Global Herceptin Biosimilar Sales, Revenue and Growth Rate (2019-2024)

Table Global Herceptin Biosimilar Sales Forecast by Regions (2019-2024)

Table Global Herceptin Biosimilar Market Share Forecast by Regions (2019-2024)

Figure North America Sales Herceptin Biosimilar Market Forecast (2019-2024)

Figure Europe Sales Herceptin Biosimilar Market Forecast (2019-2024)

Figure Asia-Pacific Sales Herceptin Biosimilar Market Forecast (2019-2024)

Figure South America Sales Herceptin Biosimilar Market Forecast (2019-2024)

Figure Middle East and Africa Sales Herceptin Biosimilar Market Forecast (2019-2024)

Table Global Herceptin Biosimilar Sales Forecast by Type (2019-2024)

Table Global Herceptin Biosimilar Market Share Forecast by Type (2019-2024)

Table Global Herceptin Biosimilar Sales Forecast by Application (2019-2024)

Table Global Herceptin Biosimilar Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Amgen

AryoGen Biopharma

Biocon

Celltrion

Gedeon Richter

Genor Biopharma

Mabion

Mylan

Roche

The Instituto Vital Brazil